|
|
Article: Healthcare utilization and costs of patients with rosacea in an insured population.
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- January 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract
Background: Rosacea is a chronic, relapsing dermatologic condition that affects an estimated 14 million people in the US. However, there is little data in the literature on the healthcare utilization and costs of patients with rosacea in insured populations.
Methods: This retrospective, observational, cohort study used the MarketScan databases to identify a rosacea cohort of patients with medical and prescription drug claims between 2002 and 2005. Inclusion criteria were 1) age 30 years and older, 2) at least one medical claim with a primary or secondary diagnosis of rosacea (ICD-9-CM 695.3), 3) at least one pharmacy claim for a rosacea topical ...